Carregant...
Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells
The proteasome inhibitor bortezomib is a promising novel agent in bladder cancer therapy; however, inducible cytoprotective mechanisms may limit its potential efficacy. To date, the cellular and molecular effects of proteasome inhibitors on bladder cancer cells have been poorly characterized. Despit...
Guardat en:
| Publicat a: | Oncol Lett |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4487089/ https://ncbi.nlm.nih.gov/pubmed/26171069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3250 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|